Title : Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma.

Pub. Date : 2015 Jan 15

PMID : 25395429






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Dinaciclib is a novel potent small molecule inhibitor of cyclin-dependent kinases (CDK)1, CDK2, CDK5, and CDK9. dinaciclib cyclin dependent kinase 2 Homo sapiens